Creative Financial Designs’s ACELYRIN SLRN Stock Holding History

Creative Financial Designs’s Portfolio SLRN Stock Details SLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-300	Closed	-$3.05K	–	1642
2023 Q3	$3.05K	Buy	+300	New	+$6.37K	﹤0.01%	1273

Other funds holding SLRN

ACMC

AyurMaya Capital Management Company Portsmouth, New Hampshire $148M AUM 24.4% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Creative Financial Designs's SLRN Position: Q4 2023 in Review

Creative Financial Designs sold out of ACELYRIN (SLRN) in Q4 2023, closing a stake of 300 shares — an estimated $3.05K sold.

Creative Financial Designs first reported a position in SLRN in Q3 2023 and held it in 1 quarter. The position peaked at $3.05K in Q3 2023. 110 funds tracked by Wall St. Rank hold SLRN as of Q4 2023.

Creative Financial Designs reported no remaining ACELYRIN position as of Q4 2023 after selling out during the quarter.
Creative Financial Designs sold 300 ACELYRIN shares in Q4 2023, an estimated $3.05K.
Creative Financial Designs first reported a position in ACELYRIN in Q3 2023 and held it in 1 quarter.
Creative Financial Designs's ACELYRIN position peaked at $3.05K in Q3 2023.
110 funds tracked by Wall St. Rank held ACELYRIN as of Q4 2023.

Based on Creative Financial Designs's 13F filing for Q4 2023, filed 10 Jan 2024.